Therapy News and Research

RSS

CAR T-Cell Therapy: The Future of Cancer and HIV Treatment?

In this interview, News-Medical speaks to Professor Jun Huang about CAR T-cell therapy and its future as a potential treatment for cancer or HIV.

20 Apr 2022

Five different diseases attack language areas in the brain that cause primary progressive aphasia

There are five different diseases that attack the language areas in the left hemisphere of the brain that slowly cause progressive impairments of language known as primary progressive aphasia (PPA), reports a new Northwestern Medicine study.

20 Apr 2022

Mutated gene found in breast cancer recurrences may help tumors to become more aggressive

A mutated gene found in more than 20% to 30% of breast cancer recurrences may help tumors become more aggressive and promote metastasis, according to a pair of new studies that uncover mechanisms behind these processes and point to new therapy targets.

20 Apr 2022

Johns Hopkins Children’s Center doctors save a newborn baby with congenital diaphragmatic hernia

Sarah Gonzalez was just 13 weeks pregnant in 2018 when she received "terrifying" news during a routine ultrasound.

19 Apr 2022

Researchers reveal possible way to treat newborns with rare genetic lung condition

When babies are born with alveolar capillary dysplasia with misalignment of pulmonary veins (ACDMPV), their skin starts to turn blue from the under-oxygenated blood in their systems.

19 Apr 2022

Mount Sinai wins $500,000 grant to support continued innovation in pancreatic cancer treatment

The Canopy Cancer Collective, a national nonprofit organization that strives to fuel better treatments and outcomes for pancreatic cancer patients, has awarded The Tisch Cancer Institute at Mount Sinai a $500,000 grant to support continued innovation in its multidisciplinary treatment of pancreatic cancer.

19 Apr 2022

Scientists create a bioengineered 3D model that mimics the biology of two rare neuromuscular diseases

A scientific team supported by the National Institutes of Health has created a tiny, bioengineered 3-D model that mimics the biology of chronic inflammatory demyelinating polyneuropathy and multifocal motor neuropathy, a pair of rare, devastating neuromuscular diseases.

19 Apr 2022

Researchers discover a novel signaling pathway that defines interferon responses in blood cancers

Northwestern Medicine investigators have discovered a novel signaling pathway activated by interferons, a group of immune system proteins, that suppresses the anti-tumor response of interferons in patients with a particular type of blood cancer, according to findings published in Nature Communications.

19 Apr 2022

NTNU researcher explores how kids are affected by coronavirus, RS virus and rhinovirus

For two years now, the novel coronavirus SARS-CoV-2 has ravaged populations the world over. Some researchers believe that the virus will mutate toward less harmless variants.

19 Apr 2022

New therapeutic option for HPV-positive head and neck carcinoma discovered

The various manifestations of head and neck carcinomas rank sixth in frequency worldwide and are fatal for about half a million people every year. In a quarter of cases, head and neck squamous cell carcinoma (HNSCC) is caused by human papillomavirus (HPV) and, currently, is not always treatable.

19 Apr 2022

Why cheap, older drugs that might treat covid never get out of the lab

In March 2020, Dr. Joseph Vinetz left the contemplative world of his Yale University infectious-disease laboratory and plunged into the covid ward at Yale New Haven Hospital, joining an army of health care workers who struggled to treat the deadly viral disease.

19 Apr 2022

As eating disorders spike during pandemic, rural treatment options lag

Erin Reynolds had battled bulimia since childhood, but the weeks before she entered treatment were among her worst. At 22, she was preparing to leave her home in Helena, Montana, for an inpatient program in New Jersey with round-the-clock medical care.

19 Apr 2022

New, longest documented case of persistent acute SARS-CoV-2 infection

Researchers describe a 16-month-old case of SARS-CoV-2 infection in an immunocompromised individual.

18 Apr 2022

Better understanding of hydrocephalus could lead to improved treatments

Hydrocephalus, or "water on the brain," occurs when the cerebral ventricles - four interconnected cavities of the brain that are filled with cerebrospinal fluid - become enlarged, but its cause is unknown in many cases.

18 Apr 2022

Latest advances in nanomaterial-based antiviral strategies

As the COVID-19 pandemic has shown, infectious diseases are a serious threat worldwide, and new strategies are needed to combat them. In recent years, nanotechnology-based antiviral agents have generated promising results.

18 Apr 2022

Noninvasive sound technology could lead to improved cancer outcomes in humans

Noninvasive sound technology developed at the University of Michigan breaks down liver tumors in rats, kills cancer cells and spurs the immune system to prevent further spread—an advance that could lead to improved cancer outcomes in humans.

18 Apr 2022

Delivery technologies of mRNA and pDNA for advanced therapeutic applications

Innovation Center of NanoMedicine (Center Director: Prof. Kazunori Kataoka) has announced that Prof. Satoshi Uchida (Principal Research Scientist), who is also Associated Professor of the Kyoto Prefectural University of Medicine, published an article review about non-viral messenger RNA (mRNA) and plasmid DNA (pDNA) delivery by addressing the various delivery technologies of mRNA and pDNA, from basic research to therapeutic and clinical application; Pharmaceutics 2022, 14(4), 810.

15 Apr 2022

Intensity and longevity of SARS-CoV-2 vaccination response in patients with immune-mediated inflammatory disease

Researchers investigated the longevity and intensity of the SARS-CoV-2 vaccine immune response in patients suffering from immune-mediated inflammatory diseases.

15 Apr 2022

A comprehensive rule book for the design of safe and efficient therapeutic cells

Therapies based on engineered immune cells have recently emerged as a promising approach in the treatment of cancer.

15 Apr 2022

How the test-to-treat pillar of the US covid strategy is failing patients

The federal "test-to-treat" program, announced in March, is meant to reduce covid hospitalizations and deaths by quickly getting antiviral pills to people who test positive. But even as cases rise again, many Americans don't have access to the program.

15 Apr 2022

Therapy News and Research

CAR T-Cell Therapy: The Future of Cancer and HIV Treatment?

Five different diseases attack language areas in the brain that cause primary progressive aphasia

Mutated gene found in breast cancer recurrences may help tumors to become more aggressive

Johns Hopkins Children’s Center doctors save a newborn baby with congenital diaphragmatic hernia

Researchers reveal possible way to treat newborns with rare genetic lung condition

Mount Sinai wins $500,000 grant to support continued innovation in pancreatic cancer treatment

Scientists create a bioengineered 3D model that mimics the biology of two rare neuromuscular diseases

Researchers discover a novel signaling pathway that defines interferon responses in blood cancers

NTNU researcher explores how kids are affected by coronavirus, RS virus and rhinovirus

New therapeutic option for HPV-positive head and neck carcinoma discovered

Why cheap, older drugs that might treat covid never get out of the lab

As eating disorders spike during pandemic, rural treatment options lag

New, longest documented case of persistent acute SARS-CoV-2 infection

Better understanding of hydrocephalus could lead to improved treatments

Latest advances in nanomaterial-based antiviral strategies

Noninvasive sound technology could lead to improved cancer outcomes in humans

Delivery technologies of mRNA and pDNA for advanced therapeutic applications

Intensity and longevity of SARS-CoV-2 vaccination response in patients with immune-mediated inflammatory disease

A comprehensive rule book for the design of safe and efficient therapeutic cells

How the test-to-treat pillar of the US covid strategy is failing patients

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News